Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesotherapy with tranexamic acid for periorbital hyperpigmentation
IRCT20240926063171N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in infraorbital hyperchromia (2 arms), sponsored by Tehran University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
infraorbital hyperchromia
Beyond the preview
Go deeper on IRCT20240926063171N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240926063171N1.